The Covid cash cow – a look at the Covid vaccine sales figures
pharmaphorum
NOVEMBER 19, 2021
Disappointing late-stage trials of CureVac’s jab meant there was no competitive advantage, while Sanofi said the dominance of current vaccines made penetration in the market difficult. Indeed, the price tags for Pfizer’s and Moderna’s jabs are substantial. Pfizer is understood to have charged $19.50 per dose in the US and €19.50
Let's personalize your content